Cell Therapy for Heart Failure: Are We There Yet?

The therapeutic potential of stem cells and cell therapy has captured the imagination of society and the medical community alike around the globe.

For over two decades, Texas Heart Institute Medical Director, Emerson Perin, MD, PhD and Dr. James T. Willerson have led clinical trials focused on improving the treatment of heart failure, heart attacks, refractory angina, and peripheral arterial disease.

In THI’s Cardiology Grand Rounds academic season closing event, Dr. Perin takes us through the journey of scientific discovery for cell therapy and discusses where we are today.